TR200101729T2 - IL-5 engelleyici 6-azaurasil türevleri - Google Patents

IL-5 engelleyici 6-azaurasil türevleri

Info

Publication number
TR200101729T2
TR200101729T2 TR2001/01729T TR200101729T TR200101729T2 TR 200101729 T2 TR200101729 T2 TR 200101729T2 TR 2001/01729 T TR2001/01729 T TR 2001/01729T TR 200101729 T TR200101729 T TR 200101729T TR 200101729 T2 TR200101729 T2 TR 200101729T2
Authority
TR
Turkey
Prior art keywords
blocker
azauracil derivatives
azauracil
derivatives
relates
Prior art date
Application number
TR2001/01729T
Other languages
English (en)
Inventor
Jean Edgard Freyne Eddy
Dirk Deroose Frederik
Fernand Armand Lacrampe Jean
Constant Johan Embrechts Werner
Michel Claude Fortin Jerome
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of TR200101729T2 publication Critical patent/TR200101729T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Bu bulus, özinofile bagli iltihapli hastaliklarin iyilestirilmesi için kullanima yönelik, 6-azaurasil türevlerini engelleyen yeni IL-5'e; bunlarin hazirlanmasi için islemlere ve bunlari içeren bilesimlere iliskindir. Bulus bundan baska bu maddelerin bir tibbi madde olarak kullanimina iliskindir.
TR2001/01729T 1998-12-18 1999-12-16 IL-5 engelleyici 6-azaurasil türevleri TR200101729T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98204336 1998-12-18

Publications (1)

Publication Number Publication Date
TR200101729T2 true TR200101729T2 (tr) 2001-10-22

Family

ID=8234494

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01729T TR200101729T2 (tr) 1998-12-18 1999-12-16 IL-5 engelleyici 6-azaurasil türevleri

Country Status (35)

Country Link
US (1) US6803364B1 (tr)
EP (1) EP1140873B1 (tr)
JP (1) JP2002533331A (tr)
KR (1) KR100635721B1 (tr)
CN (1) CN100343239C (tr)
AR (1) AR021887A1 (tr)
AT (1) ATE365723T1 (tr)
AU (1) AU773780B2 (tr)
BG (1) BG105602A (tr)
BR (1) BR9916366A (tr)
CA (1) CA2354511A1 (tr)
CO (1) CO5150147A1 (tr)
CZ (1) CZ20012062A3 (tr)
DE (1) DE69936396T2 (tr)
DK (1) DK1140873T3 (tr)
EA (1) EA004806B1 (tr)
EE (1) EE200100320A (tr)
ES (1) ES2289835T3 (tr)
HK (1) HK1042491A1 (tr)
HR (1) HRP20010455A2 (tr)
HU (1) HUP0104641A3 (tr)
ID (1) ID28880A (tr)
IL (1) IL143766A (tr)
MY (1) MY125808A (tr)
NO (1) NO319814B1 (tr)
NZ (1) NZ512748A (tr)
PL (1) PL198205B1 (tr)
PT (1) PT1140873E (tr)
SA (1) SA00201030B1 (tr)
SK (1) SK8152001A3 (tr)
TR (1) TR200101729T2 (tr)
TW (1) TWI249530B (tr)
UA (1) UA73107C2 (tr)
WO (1) WO2000037451A1 (tr)
ZA (1) ZA200104942B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466096B2 (en) * 2007-04-26 2013-06-18 Afton Chemical Corporation 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
RU2523651C2 (ru) * 2012-05-22 2014-07-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Владивостокский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО ВГМУ Минздравсоцразвития России) Способ дифференцированного контроля базисного противовоспалительного лечения бронхиальной астмы у детей и подростков
RU2506045C1 (ru) * 2012-09-05 2014-02-10 Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" Сибирского отделения РАМН Способ прогнозирования достижения контроля бронхиальной астмы
CN119161311B (zh) * 2024-11-20 2025-02-11 北京纳百生物科技有限公司 一种地克珠利抗原及其合成方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2149645A1 (de) 1970-10-07 1972-09-14 Pfizer 2-Phenyl-as-triazin-3.5-(2H,4H)-dione und die Verwendung dieser Verbindungen zur Bekaempfung der Coccidiose
US3912723A (en) 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
US3883528A (en) 1974-04-19 1975-05-13 Pfizer Preparation of 2(aryl)-as-triazine-3,5(2H,4H)-dione coccidiostats
CA1244024A (en) 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
US4631278A (en) 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
CA1331757C (en) 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
EP0476439A1 (de) 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
TW263495B (tr) 1992-12-23 1995-11-21 Celltech Ltd
GB9304920D0 (en) 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
TW403741B (en) 1993-10-15 2000-09-01 Takeda Chemical Industries Ltd Triazine derivative, production and use thereof
TW332201B (en) 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
DE69615601T2 (de) 1995-04-14 2002-07-11 Takeda Schering-Plough Animal Health K.K., Osaka Verfahren zur Herstellung von Triazinderivate
EP0831088B1 (en) * 1996-08-30 2002-11-27 Takeda Schering-Plough Animal Health K.K. 1,2,4-Triazine-3,5-dione derivatives as anticoccidial agents
CN1261881A (zh) * 1997-07-10 2000-08-02 詹森药业有限公司 作为il－5－抑制剂的6－氮杂尿嘧啶衍生物
HRP20000003A2 (en) * 1997-07-10 2000-12-31 Janssen Pharmaceutica Nv Il-5 inhibiting 6-azauracil derivatives

Also Published As

Publication number Publication date
JP2002533331A (ja) 2002-10-08
EA200100677A1 (ru) 2001-12-24
DE69936396T2 (de) 2008-06-19
AU773780B2 (en) 2004-06-03
NO20012987D0 (no) 2001-06-15
HK1042491A1 (zh) 2002-08-16
NZ512748A (en) 2004-05-28
US6803364B1 (en) 2004-10-12
PL198205B1 (pl) 2008-06-30
CN100343239C (zh) 2007-10-17
CA2354511A1 (en) 2000-06-29
SA00201030B1 (ar) 2006-10-11
WO2000037451A1 (en) 2000-06-29
AU2100100A (en) 2000-07-12
BG105602A (en) 2002-01-31
EP1140873A1 (en) 2001-10-10
ATE365723T1 (de) 2007-07-15
CZ20012062A3 (cs) 2002-03-13
KR20010080617A (ko) 2001-08-22
CO5150147A1 (es) 2002-04-29
EE200100320A (et) 2002-10-15
UA73107C2 (en) 2005-06-15
ZA200104942B (en) 2002-06-18
SK8152001A3 (en) 2002-04-04
KR100635721B1 (ko) 2006-10-17
IL143766A0 (en) 2002-04-21
NO20012987L (no) 2001-08-17
AR021887A1 (es) 2002-08-07
HUP0104641A3 (en) 2003-01-28
ID28880A (id) 2001-07-12
MY125808A (en) 2006-08-30
DK1140873T3 (da) 2007-10-15
HRP20010455A2 (en) 2002-06-30
EA004806B1 (ru) 2004-08-26
EP1140873B1 (en) 2007-06-27
TWI249530B (en) 2006-02-21
NO319814B1 (no) 2005-09-19
CN1330643A (zh) 2002-01-09
IL143766A (en) 2005-11-20
ES2289835T3 (es) 2008-02-01
HUP0104641A2 (hu) 2002-04-29
PT1140873E (pt) 2007-10-10
BR9916366A (pt) 2001-09-18
DE69936396D1 (de) 2007-08-09

Similar Documents

Publication Publication Date Title
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
TR200001203T2 (tr) Yeni birleşik maddeler
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DE69908819D1 (de) Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
TR199900046T2 (tr) Seçici siklooksijenaz-2 inhibitörleri olarak ikameli piridinler.
HUP9801240A2 (en) Oral compositions
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
TR200000009T2 (tr) Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları.
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
TR200100410T2 (tr) 2-(purin-9-il)-tetrahidrofuran-3,4-diol türevleri.
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
PT815087E (pt) Derivados de fenilo trissubstituidos
NO913923D0 (no) 17beta-substituerte-4-aza-5alfa-androstan-3-on-derivater ogfremgangsmaate ved fremstilling av disse
ATE241641T1 (de) Betulinsäure derivate zur behandlung von neuroektodermalen tumoren
IT1285770B1 (it) Composti corticoidei
ATE221879T1 (de) Kristalline paclitaxel hydrate
ATE400577T1 (de) Anellierte dihydropyrane
ES2192832T3 (es) Uso de compuestos macrolidos para tratar glaucoma.
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
ATE226947T1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung
TR200101649T2 (tr) Piperazin türevleri.
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
DE69836464D1 (de) Orale Zusammensetzung für die Behandlung von übelriechendem Atem